Traders bought shares of Monsanto Co. (NYSE:MON) on weakness during trading hours on Friday following insider selling activity. $135.47 million flowed into the stock on the tick-up and $53.93 million flowed out of the stock on the tick-down, for a money net flow of $81.54 million into the stock. Of all equities tracked, Monsanto had the highest net in-flow for the day. Monsanto traded down ($0.43) for the day and closed at $102.11Specifically, Director Charles S. Mcmillan purchased 3,500 shares of the company’s stock in a transaction dated Monday, October 10th. The shares were purchased at an average price of $103.23 per share, for a total transaction of $361,305.00. Following the transaction, the director now owns 64,009 shares of the company’s stock, valued at $6,607,649.07. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Steven Mizell sold 310 shares of the business’s stock in a transaction that occurred on Monday, October 10th. The stock was sold at an average price of $103.09, for a total transaction of $31,957.90. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by insiders.
A number of research analysts have recently issued reports on MON shares. Goldman Sachs Group Inc. set a $92.00 price target on shares of Monsanto and gave the stock a “sell” rating in a research report on Monday, June 27th. Vetr upgraded shares of Monsanto from a “buy” rating to a “strong-buy” rating and set a $116.55 price target on the stock in a research report on Monday, June 27th. Jefferies Group restated a “buy” rating on shares of Monsanto in a research report on Wednesday, June 29th. Deutsche Bank AG restated a “buy” rating and issued a $118.00 price target on shares of Monsanto in a research report on Thursday, June 30th. Finally, Piper Jaffray Cos. dropped their target price on shares of Monsanto from $127.00 to $118.00 and set an “overweight” rating on the stock in a research report on Thursday, June 30th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the stock. Monsanto has a consensus rating of “Buy” and an average target price of $114.65.
The company’s 50 day moving average is $104.39 and its 200-day moving average is $101.78. The firm has a market cap of $44.69 billion, a price-to-earnings ratio of 34.17 and a beta of 1.19.
Monsanto (NYSE:MON) last posted its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.02) by $0.09. The firm earned $2.56 billion during the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. Monsanto’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.19) EPS. On average, analysts anticipate that Monsanto Co. will post $4.89 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be given a $0.54 dividend. This represents a $2.16 annualized dividend and a dividend yield of 2.12%. The ex-dividend date is Wednesday, October 5th. Monsanto’s dividend payout ratio is presently 71.05%.
Institutional investors have recently bought and sold shares of the company. FMR LLC raised its position in Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock valued at $1,715,960,000 after buying an additional 4,851,499 shares in the last quarter. Third Point LLC acquired a new stake in Monsanto during the second quarter valued at approximately $206,820,000. Carmignac Gestion acquired a new stake in Monsanto during the second quarter valued at approximately $197,555,000. TIAA CREF Investment Management LLC increased its stake in Monsanto by 50.4% in the second quarter. TIAA CREF Investment Management LLC now owns 4,658,464 shares of the company’s stock valued at $481,732,000 after buying an additional 1,560,646 shares during the last quarter. Finally, Adage Capital Partners GP L.L.C. increased its stake in Monsanto by 205.6% in the second quarter. Adage Capital Partners GP L.L.C. now owns 1,705,121 shares of the company’s stock valued at $176,327,000 after buying an additional 1,147,200 shares during the last quarter. 79.02% of the stock is owned by hedge funds and other institutional investors.